Skip to main content
Glama

Cryptocompare

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, and non-destructive. The description adds meaningful behavioral detail: cascades through multiple endpoints, graceful degradation when GLEIF/OpenFIGI are unavailable, explicit 'unresolved' field, and the figi_candidates fallback for ambiguous matches. No contradictions with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but dense and well-organized; it front-loads the core use case and query patterns, then elaborates on details and edge cases. Every section adds value, though it could be tightened without losing crucial context.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex lookup tool with no output schema, the description covers everything an agent needs: input forms, supported entity types, ambiguity resolution, unresolved handling, enrichment degradation, and the relationship to manual lookups. It removes the need for guessing or extra probing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with both parameters already described, but the description significantly enriches semantics: clarifies that 'value' must be the entity name only (not the full noun phrase), warns about trailing security-class words, and provides concrete examples for both company and drug types. It adds genuinely useful meaning beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb and resource: resolve a user-spoken name to canonical/official identifiers. Clearly distinguishes its purpose from siblings by enumerating query patterns ('What's the ticker for…', 'find the CIK for…') and explicitly frames itself as the tool for name-to-ID conversion. The 'Use FIRST' directive separates it from other lookup or research tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit guidance: 'Use FIRST whenever you have a name but need an ID.' It details supported entity types, input formats, and edge cases (ambiguous matches, unresolved IDs, instrument types that never have a ticker). Does not explicitly list when NOT to use it or name a sibling alternative, so it stops short of a full when/when-not exclusion.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Cryptocompare toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.1/5.0
Disambiguation3/5

Several tool families overlap heavily: ask_pipeworx, its beta, and grounded variants, the six polymarket_* tools, and the three price endpoints (price, price_full, price_multi) can be confused despite distinct purposes. Long descriptions provide some disambiguation, but an agent must read carefully to select the correct tool.

Naming Consistency4/5

Tool names mostly follow snake_case with verb_noun or noun_noun patterns (all_coins, compare_entities, top_market_cap), and related families share clear prefixes (histo_*, polymarket_*). Minor deviations exist (bare verbs like remember/forget, brand names like ask_pipeworx), but the overall pattern is readable and consistent.

Tool Count2/5

With 46 tools, the server is far beyond the 3-15 well-scoped range and nearly double the 25-tool threshold for 'too many'. Many tools are unrelated to the server's apparent crypto purpose (generate_llms_txt, scan_dependency, memory helpers), making it feel like a general-purpose utility rather than a focused data service.

Completeness3/5

The crypto data surface is fairly complete (spot, historical, top lists, news, social stats, exchange metadata), and the Pipeworx meta-tools (ask_pipeworx, deep_research, entity_profile) cover a broad range of factual queries. However, there are notable gaps: no direct way to fetch pipeworx:// citation URIs, and no advanced crypto order-book/trade endpoints, leaving some workflows as dead ends.

Resources